Loading clinical trials...
Loading clinical trials...
The goal of this feasibility and pilot study is to investigate the feasibility and preliminary clinical effects of a new rule-based chatbot intervention for adolescents with anxiety symptoms. The main questions are: * Is the intervention feasible for adolescents who are experiencing anxiety symptoms? * How do the adolescents experience the use of the intervention? * Does the intervention lead to a reduction in anxiety symptoms? * Does the intervention lead to a clinically significant reliable improvement at functional level?
Anxiety is one of the most common psychiatric disorders and the anxiety symptoms typically onsets in adolescence. The anxiety symptoms may be persistent into adulthood, leading to a poorer life quality and function impairments. The goal is to prevent the development of anxiety and comorbid disorders, as well as function impairment due to anxiety symptoms. This study wishes to investigate the feasibility and preliminary clinical effects of a digital intervention in an open pre-post and 3 months follow up study. The intervention consists of a rule-based click-chatbot, combined with therapist-guidance. This study will recruit N = 30 adolescents from Norway from age 13 up to 16 years old to investigate the feasibility and preliminary clinical effects of a rule-based click chatbot-intervention, and whether it causes a reduction in anxiety symptoms and increases of life functioning. If the intervention is feasible with promising results, the study will serve as a first step to a future randomized controlled trial.
Age
13 - 16 years
Sex
ALL
Healthy Volunteers
No
Research centre for digital mental health services, Haukeland University Hospital
Bergen, Vestland, Norway
Start Date
April 27, 2023
Primary Completion Date
November 30, 2024
Completion Date
November 30, 2024
Last Updated
August 28, 2025
25
ACTUAL participants
Rule-based chatbot intervention with therapist-guidance
OTHER
Lead Sponsor
Haukeland University Hospital
Collaborators
NCT07478393
NCT07456631
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions